Immunotherapy

Article	Citations
Identifying risk factors and biomarkers for severe CIP in lung cancer patients– a retrospective case series study	71
Atezolizumab and Bevacizumab prior to liver transplantation in hepatic angiosarcoma mimicking hepatocellular carcinoma	65
Imaging of brain metastases treated with immune checkpoint inhibitors	52
Chimeric Antigen Receptor Macrophage for Glioblastoma Immunotherapy: The Way Forward	40
Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia	40
Cost–Effectiveness Analysis of Serplulimab as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma	35
CT-P13 Subcutaneous Infliximab in Gastroenterology and Rheumatology	31
An Update on the Adalimumab Biosimilar Landscape Following Approval of the First High-Concentration Biosimilar	30
Alemtuzumab-Induced Red Cell Aplasia And Other Immune Cytopenias: Not So €˜Pure’	29
Real-world Study of Hepatic Artery Infusion Chemotherapy Combined With Anti-PD-1 Immunotherapy and Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma	27
Real-World Outcomes with Immuno-Oncology Therapies in Advanced Melanoma: Final Results of the OPTIMIzE Registry Study	26
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158	25
Safety and Effectiveness of the 300 IR Sublingual House Dust Mite Allergen Immunotherapy Tablet: 2-Year Interim Analysis of a Specified Drug-Use Survey	24
Subcutaneous Immunoglobulin Use in Immunoglobulin-Naive Patients with Primary Immunodeficiency: A Systematic Review	23
Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas	22
Targeting PD-1/PD-L1 in Biliary Tract Cancer: Role and Available Data	20
Postvaccination immune-mediated hepatitis: what do we really know?	19
Treatment and Overall Survival Among Anti-PD-1-Exposed Advanced Melanoma Patients with Evidence of Disease Progression	18
Immunotherapy for Gastric Cancer: A 2021 Update	16
Immune Checkpoint Inhibitors Use and Effects on Prognosis of COVID-19 Infection: A Systematic Review and Meta-Analysis	16
Safety and Efficacy of Mutant Neoantigen-Specific T-Cell Treatment Combined Anti-Pd-1 Therapy in Stage Iv Solid Tumors	15
Durvalumab after Chemoradiotherapy in Patients with Stage III Non-Small-Cell Lung Cancer: Real-World Outcomes Versus Clinical Trial Results	15
Low-Dose Metronomic Gemcitabine Pretreatments Overcome the Resistance of Breast Cancer to Immune Checkpoint Therapy	15
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors	15
Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors	14

Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review	13
Uveitis Associated with Cancer Immunotherapy: Long-Term Outcomes	13
Adherence, persistence and treatment switching in psoriasis	13
What is the future of immune checkpoints inhibitors for metastatic triple negative breast cancers?	12
Prognostic Value of Soluble Programmed Cell Death Ligand-1 in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis	12
Efficacy of mIte Allergen Immunotherapy in Allergic Rhinitis and the Immune Synergistic Effect on Cross-Allergens	12
Anlotinib Succeeded in Rescue Therapy For Hyperprogression Induced by Immune Checkpoint Inhibitors: A Case Report	12
Cost–Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Treatment in PD-L1-Positive Metastatic Triple-Negative Breast Cancer	12
4-1BB Antibody Enhances Cytotoxic Activity of Natural Killer Cells Against Prostate Cancer Cells Via NKG2D Agonist Combined with IL-27	12
Assessing Pd-L1 Status in Mrcc Treated with First-Line Immune-Based Combinations: A Meta-Analysis	12
Checkpoint Inhibitors in BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Can they Help Spare the Bladder?	12
Cancer Immunotherapy Via Stem Cell-Derived NK Cells	12
Sintilimab-induced severe erosive hemorrhagic gastritis and pyloric obstruction: a case report and literature review	11
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management	11
SAFFRON-103: A Phase Ib Study of Sitravatinib Plus Tislelizumab in Anti-PD-(L)1 Refractory/Resistant Advanced Melanoma	11
Immune Checkpoint Inhibitors in Cholangiocarcinoma	11
Durvalumab in Advanced Cholangiocarcinoma: Is Someone Knocking Down the Door?	10
Current Immunosuppression Strategies in Pediatric Heart Transplant	10
Dendritic Cell-Based Immunotherapy: A Potential Player in Oral Cancer Therapeutics	10
Deucravacitinib in Moderate-To-Severe Psoriasis	10
Lessons From the Diagnosis and Treatment of Severe Immune Checkpoint Inhibitor-Associated Pneumonia: A Case Report	10
Emerging Advances in Nanomedicine for Breast Cancer Immunotherapy: Opportunities and Challenges	10
Immune-Checkpoint Inhibitors in Renal Transplanted Patients Affected by Melanoma: A Systematic Review	10
Molecular Interactions of Antibodies with PD-1/PD-L1 Proteins	10
Effectiveness of allergen immunotherapy with house dust mite extract for pediatric bronchial asthma	10
Liquid biopsy for guiding breast cancer immunotherapy	10
Immune Checkpoint Inhibitor-Induced Autoimmune Encephalitis in Metastatic Squamous Cell Lung Cancer	9
Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens	9
Applications and Current Challenges of Chimeric Antigen Receptor T Cells in Treating High-Grade Gliomas in Adult and Pediatric Populations	9
Human Growth Hormone Supplement Promotes Human Lymphohematopoietic Cell Reconstitution in Immunodeficient Mice	9
Immune-Related Gigantomastia: A Case Study	9
A Summertime Pause in Immunoglobulin Replacement Therapy: A Prospective Real-World Analysis	9
Indirect Comparison of Pembrolizumab Monotherapy Versus Nivolumab + Ipilimumab in First-Line Metastatic Lung Cancer	9
Poor Response to Sintilimab Plus Chemotherapy in a Pulmonary Epithelioid Hemangioendothelioma Patient: A Case Report	9
Ruxolitinib, a JAK1/JAK2 Selective Inhibitor, Ameliorates Acute and Chronic Steroid-Refractory Gvhd Mouse Models	9
Infection Rates and Tolerability of Three Different Immunoglobulin Administration Modalities in Patients with Primary Immunodeficiency Diseases	9
Effectiveness of COVID-19 Vaccines Against Omicron Variant	9
Antithymocyte Globulin for Aplastic Anemia Secondary to Pembrolizumab: A Case Report and Review of Literature	9
Integrase inhibitors: current protagonists in antiretroviral therapy	9
Treatment of Plaque Psoriasis with Deucravacitinib (POETYK PSO-1 Study): A Plain Language Summary	9
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma	8
Steroid-Dependent Polyarthritis Induced by Immune Checkpoint Inhibitor Therapy Successfully Treated with Bimekizumab	8
Fulminant immune-related colitis after dual checkpoint inhibitor therapy: case report	8
Impact of Helicobacter Pylori Infection on The Efficacy of Immune Checkpoint Inhibitors for Cancer Treatment: A Meta-Analysis	8
Ipilimumab and Nivolumab: The ‘New Kid on the Block’ in Advanced Angiosarcoma	8
A Meta-Analysis of Application of Pd-1/Pd-L1 Inhibitor-Based Immunotherapy in Unresectable Locally Advanced Triple-Negative Breast Cancer	8
Immune Checkpoint Inhibitors in Lung Tumors with Rare Histologies and Other Thoracic Malignancies	8
Late-Onset Toxicities of Monoclonal Antibodies in Cancer Patients	8
Autophagy in combination therapy of temozolomide and IFN-γ in C6-induced glioblastoma: role of non-coding RNAs	8
Therapeutic Intervention of Glioma with the Novel Antineoplastic Agent T11TS: The Story so Far	8

Abrocitinib for the Treatment of Atopic Dermatitis	8
Mepolizumab in Chronic Rhinosinusitis with Nasal Polyposis	8
Peripheral blood cytokines and outcomes with immune checkpoint blockade: a systematic review and meta-analysis	8
TOPAZ-1: A New Standard of Care for Advanced Biliary Tract Cancers?	8
Venous Thromboembolism Events in Patients with Advanced Cancer on Immune Checkpoint Inhibitors	7
Long-Term Response to Camrelizumab in a Pretreated Metastatic Mixed Testicular Germ-Cell Tumor Patient with Co-Mutations in DNA Damage-Repair Genes	7
Pembrolizumab in an HIV-infected patient with glioblastoma	7
Cost-effectiveness of Upadacitinib vs. Tofacitinib for moderate-to-severe rheumatoid arthritis in China	7
An Abscopal Effect in a Gastric Cancer Patient Treated with Combined Chemoimmunotherapy and Palliative Radiotherapy	7
Combination of Methotrexate with Oral Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: A Systematic Review	7
Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma	7
Simultaneous Inhibition of PD-1 and LAG-3: the Future of Immunotherapy?	7
Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II)	7
Infectious Adverse Events in Patients with Atopic Dermatitis Treated with Baricitinib	7
Immunotherapies for prevention and treatment of type 1 diabetes	7
Intratumoral Delivery of Immune Therapy and Gene Therapy: The Next Era for Cancer Therapy	7
Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy	7
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab	7
Ocular Toxicities in Chimeric Antigen Receptor T-Cell Therapy: A Real-World Study Leveraging FAERS Database	7
Application of immune checkpoint inhibitors in immunotherapy for gastric cancer	6
Safety and Effectiveness of a 300 IR House Dust Mite Sublingual Tablet: Descriptive 4-Year Final Analysis of a Post-Marketing Surveillance in Japan	6
The Effect of Low-Dose Chemotherapy on the Tumor Microenvironment and its Antitumor Activity Combined with Anti-PD-1 Antibody	6
Targeting the Tumor Microenvironment of Ewing Sarcoma	6
Treatment of EAE Mice with Treg, G-MDSC and IL-2: a New Insight into Cell Therapy for Multiple Sclerosis	6
Allogeneic CAR-T cells for cancer immunotherapy	6
Urothelial Carcinoma in The Era of Immune Checkpoint Inhibitors	6
Could senescent cells be the prescription for therapeutic cancer vaccines?	6
Evaluating the Effectiveness of the Charlson Comorbidity Index in Predicting Immune Checkpoint Inhibitor-Related Adverse Events	6
The Development of Litifilimab (BIIB 059) for Cutaneous and Systemic Lupus Erythematosus	6
A novel dose-adjustment protocol for interrupted subcutaneous immunotherapy in children with allergic rhinitis	6
Oncolytic Viruses in Lung Cancer Treatment: A Review Article	6
An Unusual Case of Immune-Related Gastritis in One Patient Receiving Toripalimab Therapy	6
Neoadjuvant Immunochemotherapy in the Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: A Systematic Review	6
Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapy	6
Cutaneous Metastases at the Sites of Pembrolizumab-Induced Bullous Pemphigoid Lesions in a Patient with Melanoma	6
Mirikizumab for the Treatment of Moderate to Severe Ulcerative Colitis	6
Updated Insights on Cardiac Risks of CD19-Directed Chimeric Antigen Receptor T-cell Therapy: A Pharmacovigilance Study	6
Indications and Effects of Biological Agents in the Treatment of Noninfectious Uveitis	6
Immunotherapeutic effects of TCL-E5 and TCL-E5-pulsed DCs: two novel HPV therapeutic vaccine candidates	6
Treatment of Plaque Psoriasis with Deucravacitinib (Poetyk Pso-2 Study): A Plain Language Summary	6
Infrequent Liver Injury from Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma	6
Moving Beyond Single-Agent Checkpoint Inhibition in Biliary Tract Cancers: What is the Next Frontier?	6
Chemotherapy or Chemo-Immunotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer: A Meta-Analysis	6
A New Perspective on The Potential Application of Ripk1 in the Treatment of Sepsis	6
Evaluating Axatilimab as a treatment option for chronic graft-versus-host disease	6
Fractional Exhaled Nitric Oxide in Checkpoint Inhibitor Pneumonitis: A Case Report and Literature Review	6
Pathological Findings Directing Immunotherapy in Renal Cell Carcinomas	6
Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease	6
Plain Language Summary of principles for improving the care of people with eosinophil-associated diseases	6
Efficacy of Long-Term Repeated Rituximab Treatment in Refractory Phospholipase A2 Receptor-Antibody-Related Membranous Nephropathy	5
The combination of immune checkpoint inhibitors and chemotherapy in advanced non-small-cell lung cancer: the rational choice	5
Immunotherapy in Atopic Dermatitis	5
Overcoming Immune-Resistance in Laryngeal Cancer: A Case Report of the Abscopal Effect and Nivolumab Beyond Progression	5
Current Landscape of Immunotherapy Trials in Locally Advanced and High-Risk Head and Neck Cancer	5
The Use of Dostarlimab, a Safe and Efficient Monotherapy in Msi-H Rectal Cancer Patients, an Alternative to Surgery	5
Immunotherapy for Head and Neck Squamous Cell Carcinoma: Current Status and Perspectives	5
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement	5
Anaphylaxis to Tocilizumab in Patients with Rheumatic Disease	5
A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents	5
Peptide–MHC Complexes: Dressing up to Manipulate T Cells Against Autoimmunity and Cancer	5
Pancreas-specific immune-related adverse events in patients with lung cancer: a case series study	5
Effect of Helicobacter Pylori infection on immunotherapy for gastrointestinal cancer: a narrative review	5
Combination of immunotherapy and fruquintinib in metastatic colorectal cancer: the key to overcome resistance?	5
Mirna Profiles Change During Grass Pollen Immunotherapy Irrespective of Clinical Outcome	5
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease	5
Summary of Certolizumab Pegol in Psoriasis Including Structural Features, Pharmacokinetics and Treatment	5
Bimekizumab for The Treatment of Psoriasis	5
Tsunami of Immunotherapies in the Management of Esophageal Cancer	5
Multicenter Real-World Experience with Epinephrine 0.5 mg Dosing for Anaphylaxis with Allergen Immunotherapy	5
Pd-1/L1 Inhibitors May Increase the Risk of Pericardial Disease in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis and Systematic Review	5
A CD123-Specific Chimeric Antigen Receptor Augments Anti-Acute Myeloid Leukemia Activity of Vγ9Vδ2 T Cells	5
ICAM2 is Related to Good Prognosis in Dendritic Cell Immunotherapy for Cancer	5
Abscopal Effect and Resistance Reversion in Nivolumab-Treated Non-Small-Cell Lung Cancer Undergoing Palliative Radiotherapy: A Case Report	5
Amalgamation of Nanotechnology with Chicken IgY to Enrich Therapeutic and Diagnostic Applications: A Systematic Review	5
Thyroid Function Impairment after Chemo-Immunotherapy for Advanced Nsclc: A Single Institutional Retrospective Report	5
Nutritional conditions and PFS and OS in cancer immunotherapy: the MOUSEION-010 meta-analysis	5
Successful Use of Secukinumab in Two Melanoma Patients with Immune Checkpoint Inhibitor-Induced Inflammatory Arthropathy	5
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature	5
Pembrolizumab: A New Standard of Care in Metastatic Colorectal Cancer	5
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors	5

Radiation and Resolve: Unlocking the Synergistic Potential of Radioimmunotherapy in Advanced Lung Cancer Management	5
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations	5
Pegcetacoplan Treatment for Geographic Atrophy Due to Age-Related Macular Degeneration: A Plain Language Summary of the FILLY Study	5
Peripheral Blood Eosinophil Count is Associated with Response to Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer	5
Real-World Study: Drug Reduction in Children With Allergic Rhinitis and Asthma Receiving Immunotherapy	5
Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy	4
Evidence for optimal treatment of immune-related adverse events needed – should we use extracorporeal photopheresis?	4
Safety of Subcutaneous and Sublingual Immunotherapy with Allergoids in Children: A Real-Life Pharmacovigilance Study	4
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy	4
Safety and Effectiveness of Intravenous Ct-P13 in Inflammatory Arthritis: Post-Marketing Surveillance Study in Thailand	4
Severe Pseudomembranous Keratoconjunctivitis with Deterioration of Eyesight Induced by Immune Checkpoint Inhibitors	4
Anti-PD-1 and Regorafenib Induce Severe Multisystem Adverse Events in Microsatellite Stability Metastatic Colorectal Cancer: A Case Report	4
Drug evaluation: mepolizumab in chronic obstructive pulmonary disease	4
Pharmacokinetics and Safety of CT-P17 (40 mg/0.4 ml) Versus Reference Adalimumab: Randomized Study in Healthy Japanese Adults	4
Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event	4
Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events	4
Immunoregulatory Effects of Dental Mesenchymal Stem Cells on T and B Lymphocyte Responses in Primary Sjögren's Syndrome	4
A Review of Phase Iii Clinical Trials of Us Fda-Approved Biologic Therapies for Chronic Rhinosinusitis with Nasal Polyposis	4
Enhanced Binding at Fever Temperatures of HER2 in Complex with Trastuzumab and Pertuzumab	4
Cost–Effectiveness Analysis of Nivolumab Plus Cabozantinib Versus Sunitinib as First-Line Therapy in Advanced Renal Cell Carcinoma	4
Clinical Outcomes of Immune Checkpoint Inhibitor Diabetes Mellitus at a Comprehensive Cancer Center	4
TYK2 as a Therapeutic Target in the Treatment of Autoimmune and Inflammatory Diseases	4
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy	4
Metastatic Gastric Cancer: Synergizing and Sequencing Targeted Therapy with First-Line Immunotherapy	4
Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological database	4
Pembrolizumab-Induced Follicular Eruption and Response to Isotretinoin	4
Immunoglobulin therapies for primary immunodeficiency diseases (part 1): understanding the pharmacokinetics	4
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation	4
Health-related Quality of Life in Patients with Melanoma Brain Metastases Treated with Immunotherapy	4
Tezepelumab for the Treatment of Severe Asthma: A Plain Language Summary of the PATHWAY and NAVIGATOR Studies	4
Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis	4
Late-onset recurrent immune checkpoint inhibitor-related pneumonitis after cessation of pembrolizumab: a case report	4
Immune Checkpoint Inhibitors and Combinations with Other Agents in Cholangiocarcinoma	4
Effect of Neoadjuvant Therapy on Tumor Tissue PD-L1 and VISTA Expression Levels in Non-Small-Cell Lung Cancer	4
Immune Checkpoint Inhibitors for Advanced or Metastatic Basal Cell Carcinoma: How much Evidence do we Need?	4
The role of dupilumab in the treatment of eosinophilic esophagitis	3
The Evolution of Biliary Tract Cancer: Introducing a Special Focus Issue from Immunotherapy	3
Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation	3
Autologous Enzyme-Linked Immunosorbent Facilitated Antigen Binding Detects Ige-Blocking Activity Based on Direct Competition between Allergen-specific IgE and Non-IgE	3
Welcome to The 14th Volume of Immunotherapy	3
Avoided recurrences and costs with adjuvant atezolizumab for patients with early non-small cell lung cancer in Europe	3
Immunotherapy for Head and Neck Cancer: Where do We Go from Here?	3
The Emerging Role of Immunotherapy in Biliary Tract Cancer: A Review of New Evidence and Predictive Biomarkers	3
Pathologically Complete Remission to Combination of Invariant Nk T Cells and Anti-Cd20 Antibody in a Refractory Hiv+ Diffuse Large B-Cell Lymphoma Patient	3
Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma	3
Complete Response and Survival Outcomes in Patients with Advanced Cancer on Immune Checkpoint Inhibitors	3
Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study	3
Etrasimod for the Treatment of Ulcerative Colitis	3
The role of nemolizumab in the treatment of atopic dermatitis for the adult population	3
Immunotherapy for Cholangiocarcinoma: a 2021 Update	3
Combination of Bevacizumab and Dual Immunotherapy for Extensive-Disease Small-Cell Lung Cancer: A Case Report	3
Penpulimab and Anlotinib in an Elderly Patient with Recurrent Cervical Cancer: A Case Report and Literature Review	3
Alpha/beta-defensins influence on the humoral immunity and complications in cancer of the oral cavity and oropharynx	3
Efficacy of Therapies Targeting TGF-β in Solid Tumors: a Systematic Review and Meta-Analysis of Clinical Trials	3
Combined Application of Bevacizumab and Pd-1 Blockade Displays Durable Treatment Effects by Increasing the Infiltration And Cytotoxic Function of Cd8 + T Cells in Lu	3
CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?	3
Immunology of Osteoporosis: Relevance of Inflammatory Targets for the Development of Novel Interventions	3
Cost–effectiveness of Adjuvant Atezolizumab for Patients with Stage II–IIIA PD-L1+ Non-Small-Cell Lung Cancer	3
Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases	3
Janus Kinase Inhibitors: A Future All-Rounder in Axial Spondyloarthritis?	3
Efficacy of immunotherapy in KRAS -mutant non-small-cell lung cancer with comutations	3
Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient	3
Immune Checkpoint Inhibitor-Related Chronic Pneumonitis: A Case Report and Literature Review	3
The role of immune subtyping in glioma mRNA vaccine development	3
Sintilimab Plus Sorafenib: A novel Regimen for Hepatocellular Carcinoma	3
FHL1 As a Novel Prognostic Biomarker and Correlation with Immune Infiltration Levels in Lung Adenocarcinoma	3
Efficacy of Pd-1/Pd-L1 Inhibitors in Advanced Gastroesophageal Cancer Based on Characteristics: A Meta-Analysis	3
Interpatient Variability in Mesothelin Expression Necessitates its Evaluation Before Gastric Cancer Immunotherapy	3
Is There a Role for Immune Checkpoint Inhibitors in Chordoma?	3
Surrogate end Points for Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors	3
Reversing Chemokine/Chemokine Receptor Mismatch to Enhance the Antitumor Efficacy of CAR-T Cells	3
Plain Language Summary of the VOLTAIRE-RA in Patients with Moderate-To-Severe Rheumatoid Arthritis	3
Durable Response after Immunotherapy Discontinuation for Delayed and Severe Immune-related Adverse Event: A Case Report	3
Galectin-9 and PD-L1 Antibody Blockade Combination Therapy Inhibits Tumour Progression in Pancreatic Cancer	3
Outcomes for Pembrolizumab Stratified by Pemetrexed Maintenance Post Pembrolizumab–Platinum–Pemetrexed Induction in Metastatic Non-Small-Cell Lung Cancer	3
Lichenoid Drug Eruption on the Lower Lip Caused by Anti-PD-1 Monoclonal Antibody: A Case Report and Literature Review	3
Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO study	3
A Common Approach for Fighting Tuberculosis and Leprosy: Controlling Endoplasmic Reticulum Stress in Myeloid-derived Suppressor Cells	3
Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in p	3
Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary	3
Helminth-derived biomolecules as potential therapeutics against ulcerative colitis	3
Targeting CD47 Enhanced the Antitumor Immunity of PD-L1 Blockade in B-Cell Lymphoma	3
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis in a Patient with Chronic Lymphocytic Leukemia	3
Comparing how Well Abrocitinib and Dupilumab Treat Atopic Dermatitis Signs and Symptoms: A Plain Language Summary	3
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data	2
Impact of immune-related adverse events on survival among patients with head-and-neck squamous cell carcinoma	2
Toripalimab and Fruquintinib Therapy for Colorectal Cancer after Failed Multiline Chemotherapies: A Case Report	2
Hematological Prognosticators in Metastatic Renal Cell Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis	2
Tocilizumab in Grade 4 Hepatitis Secondary to Immune Checkpoint Inhibitor: A Case Report and Review of the Literature	2
How could histotripsy change cancer immunotherapy?	2
Evaluation of Appendectomy as A Potential Risk Factor for Immune Checkpoint Inhibitor-Associated Enterocolitis	2
Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary	2
Efficacy of PD-1/PD-L1 Plus CTLA-4 Inhibitors in Solid Tumors Based on Clinical Characteristics: a Meta-Analysis	2
Use of Upadacitinib in the Treatment of Psoriatic Arthritis	2
Absence of pre-transplant T cell response against LAA is associated with Flt3-ITD mutation and increased relapse-risk in AML patients with HSCT	2